Cargando…
A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy
Autores principales: | Li, Siqi, Tajiri, Kazuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925265/ https://www.ncbi.nlm.nih.gov/pubmed/32963172 http://dx.doi.org/10.2169/internalmedicine.5962-20 |
Ejemplares similares
-
A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
por: Murakata, Yoshiko, et al.
Publicado: (2022) -
Cardiac Complications in Immune Checkpoint Inhibition Therapy
por: Tajiri, Kazuko, et al.
Publicado: (2019) -
Fatal cerebral haemorrhagic infarction due to left ventricular thrombus after healing of immune checkpoint inhibitor-associated myocarditis
por: Sakai, Shunsuke, et al.
Publicado: (2020) -
Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
por: Dal Collo, Giada, et al.
Publicado: (2023) -
Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients
por: Talukder, Suprateeka, et al.
Publicado: (2023)